Paid Clinical Trials and Focus Groups by Category |
|
|
|
Conditions: Myocardial Infarction; Left Ventricular Systolic Dysfunction; Anterior Akinesis; Apical Akinesis
Intervention:
Sponsor: Universitaire de Sherbrooke
Not yet recruiting - verified March 2010
Condition: Stroke
Interventions: Other: Mission Possible; Other: delayed mission possible
Sponsors: McGill University; Canadian Stroke Network
Recruiting - verified September 2009
Condition: Pregnant Women With Peripartum Cardiomyopathy
Intervention:
Sponsors: University of Pittsburgh; National Institutes of Health (NIH)
Recruiting - verified March 2010
Condition: Post-tetanic Count on One Arm, the Other Arm is the Control
Intervention: Device: NMT (a device that can do neurostimulation and can record the response on the stimulation by Datex)
Sponsor: Maisonneuve-Rosemont Hospital
Recruiting - verified March 2010
Condition: Coronary Artery Disease
Interventions: Drug: Bivalirudin; Drug: Heparin
Sponsor: Laval University
Active, not recruiting - verified October 2009
Condition: Endothelial Function
Interventions: Dietary Supplement: Cinnamon; Dietary Supplement: Oregano; Dietary Supplement: Ginger; Dietary Supplement: Rosemary; Dietary Supplement: Black pepper; Dietary Supplement: Placebo
Sponsors: Laval University; McCormick Canada Co
Recruiting - verified March 2010
Conditions: Cardiac Surgery; Pain; Adult; Pain Management
Intervention: Behavioral: soulageTAVIE
Sponsors: Centre hospitalier de l'Université de Montréal (CHUM); Canadian Institutes of Health Research (CIHR); GRISIIQ; FIIC; Chaire de recherche sur les nouvelles pratiques de soins infirmiers
Recruiting - verified February 2010
Conditions: Mild Cognitive Impairment; Alzheimer's Disease
Intervention:
Sponsors: Alzheimer's Disease Cooperative Study (ADCS); National Institute on Aging (NIA); National Institutes of Health (NIH)
Not yet recruiting - verified March 2010
Conditions: Pulmonary Disease, Chronic Obstructive; Bronchitis, Chronic; Emphysema
Intervention: Other: Eccentric exercise training
Sponsors: McGill University; McGill University Health Center
Recruiting - verified December 2009
Condition: Pregnancy
Intervention:
Sponsor: Universitaire de Sherbrooke
Recruiting - verified February 2010
Condition: Thrombosis
Interventions: Drug: Variation of heparin dose; Drug: Variation of heparin dose
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)
Not yet recruiting - verified February 2010
Conditions: Brain Tumor; Intracranial Pressure
Interventions: Drug: Mannitol; Drug: Mannitol
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)
Not yet recruiting - verified February 2010
Conditions: Cough; Anesthesia; Extubation
Interventions: Drug: Remifentanil; Drug: Remifentanil; Drug: lidocaine
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)
Not yet recruiting - verified February 2010
Condition: Patients With Pacemaker With Conduction Problems
Intervention: Device: Pacing mode
Sponsors: Montreal Heart Institute; Sorin Group Canada
Active, not recruiting - verified November 2009
Condition: Preterm Birth
Interventions: Procedure: Transvaginal ultrasound; Procedure: Vaginal secretion sampling
Sponsor: Universitaire de Sherbrooke
Completed - verified February 2010
Condition: Patients Undergoing Elective General Anesthesia.
Interventions: Procedure: Tracheal intubation; Procedure: Tracheal intubation
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)
Recruiting - verified March 2010
Condition: Infant Immunizations
Intervention: Biological: Pediacel® and Infanrix™-IPV/Hib
Sponsors: Dalhousie University; IWK Health Centre; Sanofi Pasteur MSD
Recruiting - verified October 2009
Condition: Psoriasis
Intervention: Drug: etanercept 50 mg
Sponsors: Innovaderm Research Inc.; Amgen
Recruiting - verified March 2010
Condition: Neuropathic Pain
Interventions: Drug: Pregabalin; Drug: Placebo
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)
Not yet recruiting - verified February 2010
Conditions: Astrocytoma, Grade IV; Giant Cell Glioblastoma; Glioblastoma Multiforme
Interventions: Radiation: External-beam radiation therapy; Drug: Temozolomide
Sponsors: Centre hospitalier de l'Université de Montréal (CHUM); Schering-Plough
Recruiting - verified February 2010
Condition: Preeclampsia
Intervention:
Sponsors: Universitaire de Sherbrooke; Fondation des étoiles
Recruiting - verified February 2010
Condition: Premature Rupture of Fetal Membranes
Intervention:
Sponsors: Universitaire de Sherbrooke; Canadian Institutes of Health Research (CIHR)
Completed - verified February 2010
Conditions: Obstetric Labor Complications; Prolonged Pregnancy
Intervention:
Sponsors: Universitaire de Sherbrooke; Fonds de la Recherche en Santé du Québec
Recruiting - verified February 2010
Conditions: Breast Cancer; Invasive Breast Cancer
Intervention: Procedure: Sentinel Lymph Node Biopsy
Sponsors: Centre hospitalier de l'Université de Montréal (CHUM); Fondation du cancer du sein du Québec
Recruiting - verified May 2009
Condition: Heart Failure
Intervention: Device: Device programming
Sponsors: Montreal Heart Institute; St. Jude Medical; Canadian Institutes of Health Research (CIHR)
Active, not recruiting - verified May 2009
Condition: Heart Failure
Interventions: Device: CRT on; Device: CRT off
Sponsors: Montreal Heart Institute; St. Jude Medical; Canadian Institutes of Health Research (CIHR)
Recruiting - verified May 2009
Condition: Malignant Melanoma
Interventions: Drug: ABI-007; Drug: Dacarbazine
Sponsors: Abraxis BioScience Inc.; University of Arizona
Recruiting - verified August 2009
Conditions: HIV Infection; Herpesvirus 2, Human; HIV Infections
Interventions: Drug: valacyclovir; Drug: Placebo
Sponsor: University Health Network, Toronto
Recruiting - verified March 2010
Conditions: Mucocutaneous Lymph Node Syndrome; Kawasaki Disease
Interventions: Drug: Etanercept; Drug: Placebo
Sponsors: Seattle Children's Hospital; FDA Office of Orphan Products Development; Amgen
Recruiting - verified March 2010
Condition: Acute Coronary Syndrome
Interventions: Drug: Apixaban; Drug: Placebo
Sponsors: Bristol-Myers Squibb; Pfizer; Duke University
Recruiting - verified October 2009
Conditions: HIV; Hepatitis C
Interventions: Behavioral: Motivational interviewing; Behavioral: Educational intervention
Sponsors: Universitaire de Sherbrooke; Fonds de la Recherche en Santé du Québec
Recruiting - verified February 2010
Condition: Venous Thromboembolism
Intervention:
Sponsors: Ottawa Hospital Research Institute; Heart and Stroke Foundation of Ontario
Recruiting - verified March 2010
Condition: Frail Elderly
Intervention: Other: Core
Sponsor: McGill University
Completed - verified March 2010
Condition: Gastroenteritis
Interventions: Drug: Lacidophil (experimental high dose); Drug: Lacidophil (experimental standard dose); Drug: Placebo
Sponsor: The Hospital for Sick Children
Recruiting - verified February 2010
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: LY2189265; Drug: Sitagliptin 100mg, 24 months; Drug: Placebo solution; Drug: Placebo tablet, 6 months; Drug: Placebo tablet, 24 months; Drug: Sitagliptin 100 mg, 18 months
Sponsors: Eli Lilly and Company; United BioSource Corporation; Tessella Inc.; Berry Consultants
Recruiting - verified March 2010
Condition: Acute Coronary Syndrome
Interventions: Drug: Clopidogrel; Drug: Prasugrel; Drug: Commercially-available Aspirin
Sponsors: Eli Lilly and Company; Daiichi Sankyo Co., Ltd.; Duke University
Recruiting - verified March 2010
Condition: Prostate Cancer
Interventions: Drug: vandetanib; Drug: Placebo
Sponsors: AstraZeneca; Canadian Urology Research Consortium
Terminated - verified February 2010
Conditions: Ovarian Carcinoma; Breast Cancer
Intervention: Drug: AZD2281
Sponsors: AstraZeneca; British Columbia Cancer Agency
Active, not recruiting - verified March 2010
Condition: Type 1 Diabetes Mellitus
Interventions: Biological: otelixizumab; Biological: placebo
Sponsors: Tolerx Inc.; Juvenile Diabetes Research Foundation
Active, not recruiting - verified March 2009
Condition: Psoriasis Vulgaris
Interventions: Drug: Etanercept 50 mg; Drug: Etanercept 50 mg; Device: nbUVB
Sponsors: Innovaderm Research Inc.; Amgen
Completed - verified March 2010
Condition: Pneumothorax
Interventions: Procedure: chest drainage; Other: close clinical observation
Sponsors: University of Calgary; Centre Hospitalier Affilie, Universitaire de Quebec; Sunnybrook Health Sciences Centre; Canadian Intensive Care Foundation
Recruiting - verified March 2010
Condition: Attention Deficit Hyperactivity Disorder
Interventions: Drug: Ritalin; Drug: Placebo
Sponsor: McGill University
Recruiting - verified March 2010
Condition: Cystic Fibrosis
Interventions: Drug: azithromycin 250 mg tablets; Drug: placebo tablets
Sponsors: CF Therapeutics Development Network Coordinating Center; Cystic Fibrosis Foundation
Completed - verified February 2010
Condition: Supraventricular Tachycardia in Infants
Intervention: Drug: digoxin and propranolol
Sponsors: University of British Columbia; The Hospital for Sick Children; University of Utah
Recruiting - verified February 2010
Condition: Breast Neoplasms
Interventions: Drug: CP-751,871 + exemestane; Drug: exemestane
Sponsors: Pfizer; Massachusetts General Hospital
Recruiting - verified March 2010
Conditions: Arthritis, Rheumatoid; Osteoarthritis
Interventions: Drug: celecoxib; Drug: Ibuprofen; Drug: Naproxen
Sponsors: Pfizer; The Cleveland Clinic
Recruiting - verified March 2010
Condition: Breast Cancer
Interventions: Drug: anastrozole; Drug: chemotherapy; Drug: exemestane; Drug: letrozole; Drug: tamoxifen citrate
Sponsors: Eastern Cooperative Oncology Group; National Cancer Institute (NCI); Southwest Oncology Group; Cancer and Leukemia Group B; American College of Surgeons; North Central Cancer Treatment Group; NCIC Clinical Trials Group; National Surgical Adjuvant Breast and Bowel Project (NSABP)
Recruiting - verified March 2010
Condition: Prostate Cancer
Interventions: Procedure: 7800 cGy/39 fractions in 8 weeks; Procedure: 6000 cGy/20 fractions in 4 weeks
Sponsors: Ontario Clinical Oncology Group (OCOG); Canadian Institutes of Health Research (CIHR); Trans-Tasman Radiation Oncology Group (TROG)
Recruiting - verified February 2010
Condition: Breast Cancer
Interventions: Radiation: 3D-CRT APBI; Radiation: WBI
Sponsors: Ontario Clinical Oncology Group (OCOG); Canadian Institutes of Health Research (CIHR); Canadian Breast Cancer Research Alliance
Recruiting - verified March 2010
Condition: Sarcoma
Interventions: Biological: PEG-interferon alfa-2b; Drug: cisplatin; Drug: doxorubicin hydrochloride; Drug: etoposide; Drug: ifosfamide; Drug: methotrexate
Sponsors: Children's Oncology Group; National Cancer Institute (NCI); University College London Hospitals
Recruiting - verified March 2010
Condition: Breast Cancer
Interventions: Drug: exemestane; Drug: tamoxifen citrate
Sponsors: International Breast Cancer Study Group; National Cancer Institute (NCI); Breast International Group
Recruiting - verified March 2010
Condition: Lymphoma
Interventions: Biological: bleomycin sulfate; Biological: filgrastim; Biological: pegfilgrastim; Drug: ABVD regimen; Drug: BEACOPP regimen; Drug: cyclophosphamide; Drug: dacarbazine; Drug: doxorubicin hydrochloride; Drug: etoposide; Drug: prednisone; Drug: procarbazine hydrochloride; Drug: vinblastine; Drug: vincristine sulfate
Sponsors: European Organization for Research and Treatment of Cancer; Lymphoma Trials Office; Groupe d'Etudes de Lymphomes de L'Adulte; Grup per l'Estudi dels Limfomes de Catalunya i Balears; NCIC Clinical Trials Group; Australasian Leukaemia and Lymphoma Group (ALLG); Nordic Lymphoma Group
Active, not recruiting - verified June 2009
Condition: Epilepsy
Intervention: Biological: Natural Progesterone
Sponsors: Beth Israel Deaconess Medical Center; Brigham and Women's Hospital; Columbia University; Dartmouth-Hitchcock Medical Center; Emory University; Johns Hopkins University; MINCEP Epilepsy Care; Montreal Neurological Institute and Hospital; Ohio State University; Thomas Jefferson University; University of Maryland; University of Southern California; University of Virginia; Weill Medical College of Cornell University
Completed - verified March 2010
Condition: Sarcoma
Interventions: Biological: dactinomycin; Drug: busulfan; Drug: doxorubicin hydrochloride; Drug: etoposide; Drug: ifosfamide; Drug: melphalan; Drug: vincristine sulfate; Procedure: autologous hematopoietic stem cell transplantation; Procedure: conventional surgery; Radiation: radiation therapy
Sponsors: University Hospitals, Leicester; National Cancer Institute (NCI); Children's Cancer and Leukaemia Group; Societe Francaise Oncologie Pediatrique; European Organization for Research and Treatment of Cancer; Gesellschaft fur Padiatrische Onkologie und Hamatologie - Germany; Gesellschaft fur Padiatrische Onkologie und Hamatologie - Austria; Swiss Group for Clinical Cancer Research; EBMT Solid Tumors Working Party; Children's Oncology Group
Recruiting - verified March 2010
Condition: Breast Cancer
Interventions: Procedure: adjuvant therapy; Radiation: radiation therapy
Sponsors: NCIC Clinical Trials Group; National Cancer Institute (NCI); National Surgical Adjuvant Breast and Bowel Project (NSABP); Radiation Therapy Oncology Group; Southwest Oncology Group; Trans-Tasman Radiation Oncology Group (TROG); North Central Cancer Treatment Group
Active, not recruiting - verified March 2010
All Categories ... by University » ... Canada » ... Quebec 
Login/sign up for more tools for finding clinical trials. Login/Sign up Here
